Coloplast (OTC:CLPBY) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.09 by 11.11 percent. This is a 66.67 percent increase over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $1.110 billion which beat the analyst consensus estimate of $1.100 billion by 0.91 percent. This is a 13.66 percent increase over sales of $976.583 million the same period last year.